A GLP-1 Receptor Agonist Inhibits Aldosterone Release in Healthy Volunteers
Some GLP-1 medications may reduce thirst or fluid intake in certain patients, while eating less can also mean getting less water from food
Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren WM, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvnne M, Scholte Op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F: European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)
They belong to completely different drug classes, work through different mechanisms, and have different effects on weight, appetite, and cardiovascular health
Research chemicals for laboratory use only Reserve Research sells peptides and research compounds strictly for in-vitro research use only